Abstract The American Cancer Society estimated around 61,090 new cases of leukemia
were diagnosed, and around 23,660 people died from this disease in the United States …

The outlook for patients with acute myeloid leukaemia has improved in the past 30 years.
Unlike other cancers, much of this progress is attributable to refinement of supportive …

Acute myeloid leukemia (AML) is characterized by an increase in the number of myeloid
cells in the marrow and an arrest in their maturation, frequently resulting in hematopoietic …

The associations of cytogenetics with complete remission (CR) rates, overall survival (OS),
and outcomes after CR were studied in 609 previously untreated AML patients younger than …

Although improvement in outcomes has occurred in younger adults with acute myeloid
leukemia (AML) during the past 4 decades, progress in older adults has been much less …

Background and Methods It is uncertain whether mortality rates among patients who have
undergone bone marrow transplantation return to the level of the mortality rates of the …

Purpose To evaluate the role of donor lymphocyte infusion (DLI) in the treatment of relapsed
acute myeloid leukemia (AML) after allogeneic hematopoietic stem cell transplantation …

Abstract The Dutch-Belgian Hemato-Oncology Cooperative Group and the Swiss Group for
Clinical Cancer Research (HOVON-SAKK) collaborative study group evaluated outcome of …

Purpose To improve the effect of allogeneic stem-cell transplantation by sequential use of
intensive chemotherapy, reduced-intensity conditioning (RIC), and prophylactic donor …

A sequential regimen of chemotherapy, reduced-intensity conditioning (RIC) for allogeneic
stem cell transplantation (SCT), and prophylactic donor lymphocyte transfusion (pDLT) was …